A randomized, double-blind, placebo-controlled study of flexible doses of levomilnacipran ER (40–120 mg/day) in patients with major depressive disorder

por Gommoll, Carl P., Greenberg, William M., Chen, Changzheng
Publicado 2014

Efficacy of levomilnacipran extended-release in improving functional impairment associated with major depressive disorder: pooled analyses of five double-blind, placebo-controlled...

por Sambunaris, Angelo, Gommoll, Carl, Chen, Changzheng, Greenberg, William M.
Publicado 2014

Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trial

por Mathews, Maju, Gommoll, Carl, Chen, Dalei, Nunez, Rene, Khan, Arif
Publicado 2015

Vilazodone efficacy in subgroups of patients with major depressive disorder: a post-hoc analysis of four randomized, double-blind, placebo-controlled trials

por Kornstein, Susan, Chang, Cheng-Tao, Gommoll, Carl P., Edwards, John
Publicado 2018

Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study

por Mago, Rajnish, Forero, Giovanna, Greenberg, William M., Gommoll, Carl, Chen, Changzheng
Publicado 2013

Erratum to: Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study

por Mago, Rajnish, Forero, Giovanna, Greenberg, William M., Gommoll, Carl, Chen, Changzheng
Publicado 2013

Evaluating the efficacy of vilazodone in achieving remission in patients with major depressive disorder: post-hoc analyses of a phase IV trial

por Citrome, Leslie, Gommoll, Carl P., Tang, Xiongwen, Nunez, Rene, Mathews, Maju
Publicado 2015

Efficacy of levomilnacipran extended-release in major depressive disorder: pooled analysis of 5 double-blind, placebo-controlled trials

por Montgomery, Stuart A., Gommoll, Carl P., Chen, Changzheng, Greenberg, William M.
Publicado 2014

Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: results from a phase IV clinical trial

por Clayton, Anita H., Gommoll, Carl, Chen, Dalei, Nunez, Rene, Mathews, Maju
Publicado 2015

Effects of levomilnacipran extended-release on motivation/energy and functioning in adults with major depressive disorder

por Thase, Michael E., Gommoll, Carl, Chen, Changzheng, Kramer, Kenneth, Sambunaris, Angelo
Publicado 2016

Categorical improvements in disease severity in patients with major depressive disorder treated with vilazodone: post hoc analysis of four randomized, placebo-controlled trials

por Durgam, Suresh, Chen, Changzheng, Gommoll, Carl P, Edwards, John, Citrome, Leslie
Publicado 2016

The efficacy of extended-release levomilnacipran in moderate to severe major depressive disorder: secondary and post-hoc analyses from a randomized, double-blind, placebo-controlle...

por Montgomery, Stuart A., Mansuy, Lucilla, Ruth, Adam C., Li, Dayong, Gommoll, Carl
Publicado 2014

Characterizing sexual function in patients with generalized anxiety disorder: a pooled analysis of three vilazodone studies

por Clayton, Anita H, Durgam, Suresh, Tang, Xiongwen, Chen, Changzheng, Ruth, Adam, Gommoll, Carl
Publicado 2016

Post Hoc Analyses of Anxiety Measures in Adult Patients With Generalized Anxiety Disorder Treated With Vilazodone

por Khan, Arif, Durgam, Suresh, Tang, Xiongwen, Ruth, Adam, Mathews, Maju, Gommoll, Carl P.
Publicado 2016

Vilazodone in patients with generalized anxiety disorder: a double-blind, randomized, placebo-controlled, flexible-dose study

por Gommoll, Carl, Forero, Giovanna, Mathews, Maju, Nunez, Rene, Tang, Xiongwen, Durgam, Suresh, Sambunaris, Angelo
Publicado 2015

Effects of levomilnacipran ER on fatigue symptoms associated with major depressive disorder

por Freeman, Marlene P., Fava, Maurizio, Gommoll, Carl, Chen, Changzheng, Greenberg, William M., Ruth, Adam
Publicado 2016

A Phase III, Double-Blind, Placebo-Controlled, Flexible-Dose Study of Levomilnacipran Extended-Release in Patients With Major Depressive Disorder

por Sambunaris, Angelo, Bose, Anjana, Gommoll, Carl P., Chen, Changzheng, Greenberg, William M., Sheehan, David V.
Publicado 2014

A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, FIXED-DOSE PHASE III STUDY OF VILAZODONE IN PATIENTS WITH GENERALIZED ANXIETY DISORDER

por Gommoll, Carl, Durgam, Suresh, Mathews, Maju, Forero, Giovanna, Nunez, Rene, Tang, Xiongwen, Thase, Michael E
Publicado 2015

Effects of levomilnacipran extended-release on major depressive disorder patients with cognitive impairments: post-hoc analysis of a phase III study

por Wesnes, Keith A., Gommoll, Carl, Chen, Changzheng, Sambunaris, Angelo, McIntyre, Roger S., Harvey, Philip D.
Publicado 2017

Relapse prevention in adults with major depressive disorder treated with vilazodone: a randomized, double-blind, placebo-controlled trial

por Durgam, Suresh, Gommoll, Carl, Migliore, Raffaele, Chen, Changzheng, Chang, Cheng-Tao, Aguirre, Michelle, Thase, Michael E.
Publicado 2018